Re:23andMe Is Monetizing Your DNA the Way Facebook Monetizes...
by jonlucc on Sunday July 10, 2016 @05:11PM
(#12067290)
They've also been offering to pharma companies the ability to help find cohorts of patients to make clinical trials much cheaper.
Say we have a drug we think works in a sliver of patients with muscular dystroph; we can either go screen tons of diagnosed patients to find the cohort we think will respond, or we can go ask 23andMe to send some patients with the required genetic profile our way.
Say we have a drug we think works in a sliver of patients with muscular dystroph; we can either go screen tons of diagnosed patients to find the cohort we think will respond, or we can go ask 23andMe to send some patients with the required genetic profile our way.